Most downloaded

Review paper2023, dec 5

Systemic treatment in triple-negative breast cancer patients — standard and novel approaches

Sylwia Dębska-Szmich, Piotr Potemski

Review paper

DOI: 10.5603/ocp.96485

Guidelines / Expert consensus2023, oct 17

Management of melanoma central nervous system metastases

Piotr Rutkowski, Dorota Kiprian, Tomasz Świtaj, Radosław Michalik, Mateusz Spałek, Katarzyna Kozak, Tomasz Mandat, Bożena Cybulska-Stopa, Monika Dudzisz-Śledź

Ahead of print

Guidelines / Expert consensus

DOI: 10.5603/OCP.2023.0042

Review paper2023, oct 25

Diagnosis and treatment of patients with breast cancer and mutation in the BRCA1/2 genes

Joanna Kufel-Grabowska, Bartosz Wasąg

Ahead of print

Review paper

DOI: 10.5603/OCP.2023.0035

Research paper2023, nov 24

Between “opioidophobia” and the opioid crisis: a cross-sectional comparison of opinions on opioid analgesic treatment between palliative care patients with cancer and physicians in Poland

Maria Wysocka, Anna Kieszkowska-Grudny, Jakub Klimkiewicz, Jerzy Jarosz, Martyna Hordowicz, Andrzej Silczuk, Tomasz Pasierski, Anna Klimkiewicz

Ahead of print

Research paper

DOI: 10.5603/ocp.96515

Research paper2023, oct 25

Systemic treatment of patients with advanced pancreatic cancer — is there still a place for gemcitabine in the first-line setting? Experience of Polish oncology centers

Ireneusz Raczyński, Patryk Zając, Joanna Streb, Bogumiła Czartoryska-Arłukowicz, Aleksandra Chruściana-Bołtuć, Małgorzata Talerczyk, Katarzyna Wierzbicka, Agnieszka Siedlaczek, Weronika Radecka, Michał Jurczyk, Barbara Radecka

Ahead of print

Research paper

DOI: 10.5603/ocp.97305

Review paper2024, jan 24

Rechallenge of immunotherapy in non-small cell lung cancer patients — navigating indications and evolving perspectives

Magdalena Knetki-Wróblewska, Izabela Chmielewska, Kamila Wojas-Krawczyk, Maciej Krzakowski

Ahead of print

Review paper

DOI: 10.5603/ocp.98328

Research paper2023, nov 14

Two-center experience comparing the use of the FLOT4 and CROSS schemes for patients with gastric, esophageal, and gastroesophageal junction adenocarcinoma

Irene Solana López, David Gutiérrez Abad, Maria Victoria de Torres Olombrada, Elia Martínez Moreno, Ignacio Juez Martel, Alicia Hurtado Nuño, Ana Manuela Martín Fernández de Soignie, Carlos de Zea Luque, Nadia Sánchez Baños, Fátima Escalona Martín, Beatriz Losada Vila, Carmen Pantín González, Laura Rodríguez Lajusticia, Diego Malón Giménez, Beatriz Jiménez Munarriz, Roberto Hernández López, Julia Calzas Rodríguez, Juan Antonio Guerra Martínez

Ahead of print

Research paper

DOI: 10.5603/ocp.97428

Review paper2023, sep 22

Pembrolizumab in combination with chemotherapy in patients with advanced squamous cell lung cancer — clinical trials and real-world data

Magdalena Knetki-Wróblewska, Dariusz M. Kowalski

Ahead of print

Review paper

DOI: 10.5603/OCP.2023.0047

Research paper2023, oct 25

The relationship between inflammation markers, positron emission tomography/ /computed tomography parameters and disease prognosis in advanced non-small-cell lung cancer patients

Esra Pirinççi, Zeynep Oruç, Senar Ebinç, Yunus Güzel, Halil Kömek, Mehmet Küçüköner, Zuhat Urakçı, Muhammet Ali Kaplan, Bekir Taşdemir, Abdurrahman Işıkdoğan

Ahead of print

Research paper

DOI: 10.5603/ocp.97451

Case report2023, oct 17

Cardiac metastasis of lung cancer diagnosed by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT)

Yassir Benameur, Salah Nabih Oueriagli, Omar Ait Sahel, Abderrahim Doudouh

Vol 20, No 2 (2024)

Case report

DOI: 10.5603/ocp.95808

Oncol Clin Pract 2024;20(2):144-147.

Review paper2024, feb 5

Trifluridine/tipiracil (FTD/TPI) in metastatic colorectal cancer treatment

Patryk S. Michel, Marek Jankowski, Dawid Sigorski, Tomasz Kubiatowski

Ahead of print

Review paper

DOI: 10.5603/ocp.97486

Case report2023, dec 5

Tumor heterogeneity and its impact on sotorasib response in a patient with non-small cell lung cancer

Karolina P. Nalewaj, Izabela Chmielewska, Paweł Krawczyk, Anna Grenda, Luiza Grzycka-Kowalik, Iwona Paśnik, Janusz Milanowski

Ahead of print

Case report

DOI: 10.5603/ocp.97722

Research paper2023, dec 6

Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index as clinical predictive and prognostic markers in patients with advanced pancreatic cancer receiving gemcitabine monotherapy

Ireneusz Raczyński, Agnieszka Siedlaczek, Joanna Streb, Patryk Zając, Bogumiła Czartoryska-Arłukowicz, Aleksandra Chruściana-Bołtuć, Małgorzata Talerczyk, Katarzyna Wierzbicka, Weronika Radecka, Michał Jurczyk, Barbara Radecka

Ahead of print

Research paper

DOI: 10.5603/ocp.98125

Commentary2023, oct 10

Commentary on Encorafenib plus cetuximab in patients with BRAFV600E-mutated metastatic colorectal cancer — Polish multicenter experience

Barbara Radecka

Ahead of print

Commentary

DOI: 10.5603/ocp.97067

Research paper2023, nov 6

The effect of different concentrations of anti-PD-1 and anti-PD-L1 antibodies on the activity of immune system cells in patients with non-small cell lung cancer

Aleksandra Bożyk, Kamila Wojas-Krawczyk, Marcin Nicoś, Paweł Krawczyk

Vol 20, No 2 (2024)

Research paper

DOI: 10.5603/ocp.96792

Oncol Clin Pract 2024;20(2):124-135.

Review paper2024, feb 27

Malignant peripheral nerve sheath tumor — from genetics to multidisciplinary treatment

Anna M. Czarnecka, Paulina Chmiel, Paweł Sobczuk, Ewa Bartnik, Mateusz Spałek, Anna Szumera-Ciećkiewicz, Marcin Zdzienicki, Sławomir Falkowski, Piotr Rutkowski

Ahead of print

Review paper

DOI: 10.5603/ocp.98716

Case report2023, dec 11

Chemotherapy in patients with testicular germ-cell tumors and end-stage renal disease requiring hemodialysis: two case reports

Martyna Tyszka, Letycja Róg, Jolanta Małyszko, Rafał Stec

Ahead of print

Case report

DOI: 10.5603/ocp.96750

Clinical vignette2024, jan 31

Trichomegaly as a rare complication of panitumumab therapy for colon cancer

Jakub Krzysztof Gałązka, Katarzyna Szklener, Paweł Polski, Mariusz Matuszek, Sławomir Mańdziuk